Biotest Aktiengesellschaft (HAM:BIO3)
30.00
0.00 (0.00%)
At close: Jul 29, 2025
Innovid Market Cap
HAM:BIO3 has a market cap or net worth of €1.40 billion as of July 31, 2025. Its market cap has increased by 1.88% in one year.
Market Cap
1.40B
Enterprise Value
2.02B
Revenue
635.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$30.00
Market Cap Chart
Since December 31, 1997, HAM:BIO3's market cap has increased from 226.35M to 1.40B, an increase of 517.12%. That is a compound annual growth rate of 6.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 6, 2025 | 1.40B | 3.52% |
Dec 30, 2024 | 1.35B | -7.34% |
Dec 29, 2023 | 1.46B | -4.17% |
Dec 30, 2022 | 1.52B | -5.54% |
Dec 30, 2021 | 1.61B | 42.88% |
Dec 30, 2020 | 1.13B | 43.32% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 289.34B |
Siemens Aktiengesellschaft | 176.66B |
Deutsche Telekom AG | 154.36B |
Allianz SE | 131.75B |
Rheinmetall AG | 79.50B |
Siemens Energy AG | 77.36B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.55B |
Deutsche Bank Aktiengesellschaft | 54.97B |